ABSTRACTIn this paper the authors reviews the anaemia in cancer patients, its mechanisms, diagnosis, and therapeutics, especially the indications for blood transfusion and the use of recombinant human erythropoietin. Also, the author reviews the impact of anaemia in quality of life and in the outcome of therapy and of cancer itself.REV PORT PNEUMOL 2003; IX (2): 117-12
Anaemia is a common complication in cancer patients. The decrease in haemoglobin is associated with ...
Clelia Madeddu,1 Manuela Neri,2 Elisabetta Sanna,2 Sara Oppi,3 Antonio Macciò2 1Department of Medica...
The prevalence of anaemia in patients with cancer lies between 10 and 40%, depending on the type of ...
Development of anemia during chemotherapy or chemoradiotherapy of malignancies is a serious adverse ...
Anaemia is a frequent finding in cancer and may be due to different causes. In untreated subjects, t...
hotmail.com Anaemia and cancer treatment: a conceptual change Khan F A, Shukla A N, Joshi S C Anaemi...
Increasingly, anemia is being recognized as a negative prognostic and predictive factor for patients...
Cancer-related anemia, blood products management, erythropoi-esis stimulating agents, ESA, blood pro...
Anemia is a common feature in c.40% of patients at the time of cancer diagnosis and in more than hal...
Thesis (M.Nurs.), College of Nursing, Washington State UniversityAnemia is the most common hematolog...
Anaemia effects up to 90 % of cancer patients, with more than 60 % requiring blood transfusion durin...
Main mechanisms involved in the development of chemother-apy-induced anemia are the direct bone marr...
Background : Patients with advanced cancer frequently experience clinically significant anemia, whic...
Anemia is one of the most common complications of cancer. The severity of anemia depends on the seve...
Background: Anemia associated with cancer and cancer therapy is an important clinical and economic f...
Anaemia is a common complication in cancer patients. The decrease in haemoglobin is associated with ...
Clelia Madeddu,1 Manuela Neri,2 Elisabetta Sanna,2 Sara Oppi,3 Antonio Macciò2 1Department of Medica...
The prevalence of anaemia in patients with cancer lies between 10 and 40%, depending on the type of ...
Development of anemia during chemotherapy or chemoradiotherapy of malignancies is a serious adverse ...
Anaemia is a frequent finding in cancer and may be due to different causes. In untreated subjects, t...
hotmail.com Anaemia and cancer treatment: a conceptual change Khan F A, Shukla A N, Joshi S C Anaemi...
Increasingly, anemia is being recognized as a negative prognostic and predictive factor for patients...
Cancer-related anemia, blood products management, erythropoi-esis stimulating agents, ESA, blood pro...
Anemia is a common feature in c.40% of patients at the time of cancer diagnosis and in more than hal...
Thesis (M.Nurs.), College of Nursing, Washington State UniversityAnemia is the most common hematolog...
Anaemia effects up to 90 % of cancer patients, with more than 60 % requiring blood transfusion durin...
Main mechanisms involved in the development of chemother-apy-induced anemia are the direct bone marr...
Background : Patients with advanced cancer frequently experience clinically significant anemia, whic...
Anemia is one of the most common complications of cancer. The severity of anemia depends on the seve...
Background: Anemia associated with cancer and cancer therapy is an important clinical and economic f...
Anaemia is a common complication in cancer patients. The decrease in haemoglobin is associated with ...
Clelia Madeddu,1 Manuela Neri,2 Elisabetta Sanna,2 Sara Oppi,3 Antonio Macciò2 1Department of Medica...
The prevalence of anaemia in patients with cancer lies between 10 and 40%, depending on the type of ...
DOI
Add to ORKG